Skip to main content

STANCE CAPITAL LLC

Position in NVAX — Novavax Inc

CIK 2056334 BOSTON, MA

Position in NVAX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$4,070
-$265 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STANCE CAPITAL LLC holds $54,976 across 3 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,070 500
2025-09-30 $4,335 500
2024-12-31 $4,020 500